Filing Details
- Accession Number:
- 0001225208-13-012781
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-20 16:17:33
- Reporting Period:
- 2013-05-16
- Filing Date:
- 2013-05-20
- Accepted Time:
- 2013-05-20 16:17:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1198959 | M James Cornelius | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Disposition | 2013-05-16 | 10,000 | $43.24 | 751,824 | No | 4 | S | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2013-05-17 | 205,996 | $22.14 | 957,820 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2013-05-17 | 10,000 | $43.00 | 947,820 | No | 4 | S | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2013-05-17 | 205,996 | $42.98 | 741,824 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Executive Option (right to buy) | Disposition | 2013-05-17 | 205,996 | $0.00 | 205,996 | $22.14 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 200,000 | 2018-03-03 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.65 to $44.45, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.71 to $43.33, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.71 to $43.43, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- As Mr. Cornelius had attained age 60, this stock option award vested 100% on the first anniversary of the grant date, which was March 4, 2009.
Billionaire Hedge Funds
